Fenbufen-d9 是 Fenbufen 的氘代物。Fenbufen (CL-82204) 是一种具有口服活性的非甾体抗炎化合物 (NSAID)，具有缓解疼痛、解热作用。Fenbufen 在各种动物模型中都有强大的活性，包括角叉菜素水肿、紫外线红斑、佐剂性关节炎等。Fenbufen 对 COX-1 和 COX-2 具有抑制活性，其 IC50 分别为 3.9 μM 和 8.1 μM。Fenbufen 具有 caspases (caspase-1, 3, 4, 5, 9) 抑制活性 。
| 生物活性 |
Fenbufen-d9 (CL-82204-d9) is the deuterium labeled Fenbufen. Fenbufen (CL-82204) is an orally active non-steroidal anti-inflammatory drug (NSAID), with antipyretic effects. Fenbufen has potent activity in a variety of animal model, including carageenin edema, UV erythema and adjuvant arthritis. Fenbufen has inhibitory activities against COX-1 and COX-2 with IC50s of 3.9 μM and 8.1 μM, respectively. Fenbufen is a caspases (caspase-1, 3, 4, 5, 9) inhibitor. |
|---|---|
| 体外研究 |
Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs. |
| 分子量 |
263.34
|
| CAS号 |
1189940-96-2
|
| 运输条件 |
Room temperature in continental US; may vary elsewhere. |
| 储存方式 |
Please store the product under the recommended conditions in the Certificate of Analysis. |
纯度： 98%
关注我们
获得KKL MED 最新资讯
咨询热线：
400-881-9290
Data Sheet